Literature DB >> 7707475

Color Doppler ultrasonography in the identification of communicating vessels in twin-twin transfusion syndrome and acardiac twins.

K Hecher1, Y Ville, K H Nicolaides.   

Abstract

This study evaluates the role of color Doppler ultrasonography in the identification of the communicating placental vessels in pregnancies with twin-twin transfusion syndrome and acardiac twins. In 18 pregnancies with twin-twin transfusion syndrome and two with an acardiac twin, color Doppler studies of the placental vasculature were performed before fetoscopy for laser coagulation of the communicating vessels. In six cases of twin-twin transfusion syndrome the placental attachment of the intertwin membrane could be visualized. Pulsatile arterial blood flow was observed from the donor to the recipient twin that disappeared after laser therapy. In both cases of acardiac twins, one communicating vessel with pulsatile and another vessel with nonpulsatile blood flow in the opposite direction could be identified. Color Doppler imaging is unlikely to play a major role in assisting endoscopic laser separation of chorioangiopagus in patients with acute polyhydramnios, but it may prove to be useful in the early identification of pregnancies at risk of developing twin-twin transfusion syndrome.

Entities:  

Mesh:

Year:  1995        PMID: 7707475     DOI: 10.7863/jum.1995.14.1.37

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  2 in total

1.  Twin reversed arterial perfusion sequence-a rare and dangerous complication form of monochorionic twins: A case report.

Authors:  Nguyen Duy Anh; Nguyen-Thi Thu Ha; Nguyen-Thi Sim; Nguyen Khac Toan; Phan-Thi Huyen Thuong; Nguyen Minh Duc
Journal:  World J Clin Cases       Date:  2022-10-06       Impact factor: 1.534

2.  Twin Reversed Arterial Perfusion (TRAP) Sequence; Characteristic Gray-Scale and Doppler Ultrasonography Findings.

Authors:  Ayla Buyukkaya; Guven Tekbas; Ramazan Buyukkaya
Journal:  Iran J Radiol       Date:  2015-07-22       Impact factor: 0.212

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.